Evidence map›Paper›PMID 32410493›Full record

SynthesisJournal of the American Heart Association2020

Clinical and Angiographic Outcomes With Drug-Coated Balloons for De Novo Coronary Lesions: A Meta-Analysis of Randomized Clinical Trials.

Islam Y Elgendy, Mohamed M Gad, Akram Y Elgendy, Ahmad Mahmoud, Ahmed N Mahmoud, Javier Cuesta, Fernando Rivero, Fernando Alfonso

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 8 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 8 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Efficacy of Drug-Coated Balloon Approaches forFrontiers in cardiovascular medicine · 2022
    Pooled it
  8. Pooled it
  9. Coronary vasomotion after treatment with drug-coated balloons or drug-eluting stents: a prospective, open-label, single-centre randomised trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Trial
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. A Comparison of 2 Paclitaxel-Coated Balloon Systems in Treatment of De Novo Coronary Artery Lesions.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Islam Y ElgendyDivision of Cardiology Massachusetts General Hospital and Harvard Medical School Boston MA.
Mohamed M GadDepartment of Medicine Cleveland Clinic Foundation Cleveland OH.
Akram Y ElgendyDivision of Cardiovascular Medicine University of Florida Gainesville FL.
Ahmad MahmoudDivision of Cardiovascular Medicine University of Florida Gainesville FL.
Ahmed N MahmoudDivision of Cardiology University of Washington Seattle WA.
Javier CuestaCardiology Department Hospital Universitario de La Princesa IIS-IP CIBER-CV Universidad Autónoma de Madrid Spain.
Fernando RiveroCardiology Department Hospital Universitario de La Princesa IIS-IP CIBER-CV Universidad Autónoma de Madrid Spain.
Fernando AlfonsoCardiology Department Hospital Universitario de La Princesa IIS-IP CIBER-CV Universidad Autónoma de Madrid Spain.
University of Florida · USCentro de Investigación en Red en Enfermedades Cardiovasculares · ESCleveland Clinic · USHospital Universitario de La Princesa · ESMassachusetts General Hospital · USUniversidad Autónoma de Madrid · ESUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The role of drug-coated balloons (DCBs) in the treatment of de novo coronary lesions is not well established. Methods and Results Electronic databases and major conference proceedings were searched for randomized controlled trials that compared DCBs with stents or angioplasty for de novo coronary lesions. The primary outcome was target lesion revascularization. Summary estimates were conducted using random-effects analysis complemented by several subgroup and sensitivity analyses. A total of 14 randomized controlled trials with 2483 patients were included. At a mean follow up of 12 months, DCBs were associated with no difference in the incidence of target lesion revascularization as compared with alternative strategies (risk ratio [RR], 0.79; 95% CI, 0.35-1.76). There was no difference in treatment effect based on the indication (ie, small-vessel disease, myocardial infarction, bifurcation, or high bleeding risk) (

Indexed as

Cardiac CathetersCoated Materials, BiocompatibleCoronary AngiographyAngioplasty, Balloon, CoronaryCoronary Artery DiseaseHumansPredictive Value of TestsRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTreatment OutcomeCoated Materials, Biocompatiblecoronary artery diseasede novo lesionsdrug‐coated balloondrug‐eluting stentmeta‐analysismortalitysmall vessels

Identifiers

PMID32410493
PMCPMC7660863
OpenAlexW3024443995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.